Drugs / Choline Salicylate
Choline Salicylate
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT04640779 | Feb 2021 → Nov 2025 | Hodgkins lymphoma, histiocytic and dendritic cell neoplasm, non-Hodgkin lymphoma, plasma cell myeloma | Mayo Clinic | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT06531720 | Jan → Dec 2023 | ulcerative stomatitis | Medical University of Silesia | Completed | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Choline Salicylate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04640779 ↗ |
| Known as | Choline salicylic acid salt | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104095 ↗ |
| Known as | Choline subsalicylate | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104095 ↗ |
| Known as | CHS | “The aim of the study was comparing the effectiveness of oral mucosa healing properties of different preparations: CHX=0,2% chorhexidine digluconate, CHS=8,7% choline...” NCT06531720 ↗ |
| Known as | Dinnefords | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104095 ↗ |
| Known as | Salicilato de colina | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104095 ↗ |
| Known as | Salicylate de choline | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104095 ↗ |
| Known as | Salicylic acid choline salt | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104095 ↗ |
| Modality | Small molecule | — CHEMBL2104095 ↗ |
| Route | Oral | “Given PO” NCT04640779 ↗ |